US, Europe to be focus markets for future growth: Wockhardt

Last Updated: Tuesday, December 4, 2012, 13:11

Drug maker Wockhardt Tuesday said it expects the US and European markets to continue to be its mainstay in the coming years while it seeks to enhance R&D capabilities and focus on introducing new advanced therapies.

NPPA demands Rs 130 crore from drug makers for overcharging: Jena

Last Updated: Thursday, November 22, 2012, 16:01

The National Pharmaceutical Pricing Authority (NPPA) has raised a fresh demand of nearly Rs 130 crore from various drug makers, including Claris Life Sciences, for overcharging during the current year till October 2012, Parliament was informed on Thursday.

Sun Pharma Q3 net nearly doubles

Last Updated: Monday, February 13, 2012, 17:49

Sun Pharmaceutical Industries Ltd, India's top drugmaker by market capitalisation, reported a better-than-expected 91 percent rise in December quarter net profit on robust sales by Israeli unit Taro Pharmaceutical Industries.